Literature DB >> 27590199

Breast cancer-specific mortality in small-sized tumor with node-positive breast cancer: a nation-wide study in Korean breast cancer society.

Jai Min Ryu1, Hyouk Jin Lee2, Tae In Yoon3, Eun Sook Lee4, Soo Jung Lee5, Jin Hyang Jung6, Byung Joo Chae7, Seok Jin Nam1, Jeong Eon Lee1, Se Kyung Lee1, Soo Youn Bae1, Jonghan Yu1, Seok Won Kim8.   

Abstract

Tumor size and number of lymph node (LN) metastases are well known as the most important prognostic factors of breast cancer. We hypothesized that very small breast cancers with LN metastasis represent a progressive biologic behavior and evaluated tumor size stratified by LN metastasis. Data between 1990 and 2010 were obtained retrospectively from the Korean Breast Cancer Society Registry with inclusion criteria of female, non-metastatic, unilateral, and T1/2 breast cancer. We collected the following variables: age at surgery, tumor size, number of LN metastases, nuclear grade (NG), lymphovascular invasion (LVI), estrogen receptor status, progesterone receptor status, and epidermal growth factor receptor-2 status. Patient characteristics were compared by means of independent t-tests for continuous variables and the Chi-square or Fisher's exact test for categorical variables. Kaplan-Meier curves, with corresponding results of log-rank tests, were constructed for breast cancer-specific survival (BCSS). Five- and eight-year breast cancer-specific mortality (BCSM) was obtained in groups of 300 patients, followed by smoothing according to the confidence interval using the lowess method. We identified 39,826 breast cancer patients who met the inclusion criteria. Among them, 1433 (3.6 %) patients died due to breast cancer. The median follow-up duration was 63.4 (3-255) months. In the multivariate analysis, age at surgery, NG, LVI, subtype, and tumor size-nodal interactions were independently associated with BCSM. The N1 group had lower BCSS for T1a than T1b. The N2+ group also had lower BCSS for T1b than T1c or T2. In the N1 group of tumors smaller than 10 mm, 5- and 8-year BCSM decreased with larger tumor size. Patients with very small tumors with LN metastasis have decreased BCSM according to increase tumor size. Small tumors with LN metastasis could have aggressive biological behavior.

Entities:  

Keywords:  Breast neoplasm; Lymph node; Mortality

Mesh:

Year:  2016        PMID: 27590199     DOI: 10.1007/s10549-016-3943-4

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  4 in total

1.  Blood cadmium levels associated with short distant metastasis-free survival time in invasive breast cancer.

Authors:  Yuanfang He; Lin Peng; Yanhong Huang; Caixia Liu; Shukai Zheng; Kusheng Wu
Journal:  Environ Sci Pollut Res Int       Date:  2017-10-09       Impact factor: 4.223

2.  An analysis of Ki-67 expression in stage 1 invasive ductal breast carcinoma using apparent diffusion coefficient histograms.

Authors:  Maolin Xu; Qi Tang; Manxiu Li; Yulin Liu; Fang Li
Journal:  Quant Imaging Med Surg       Date:  2021-04

3.  Tumour size and overall survival among surgically treated patients with non-metastatic colon cancer in the U.S. Military Health System.

Authors:  Melannie Alexander; Jie Lin; Craig D Shriver; Katherine A McGlynn; Kangmin Zhu
Journal:  Colorectal Dis       Date:  2020-10-27       Impact factor: 3.917

4.  The effect of adjuvant chemotherapy on survival in Korean patients with node negative T1c, triple negative breast cancer.

Authors:  Seung Taek Lim; Chan Heun Park; Sung Yong Kim; Seok Jin Nam; Eun Young Kang; Byung-In Moon; Hyouk Jin Lee; Ye Won Jeon; Hongki Gwak; Young Jin Suh
Journal:  PLoS One       Date:  2018-05-16       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.